Centre for Health Behaviours Research, School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Int J Health Policy Manag. 2022 Jul 1;11(7):1090-1101. doi: 10.34172/ijhpm.2021.02. Epub 2021 Jan 9.
The prevalence of coronavirus disease 2019 (COVID-19) vaccination is very critical in controlling COVID-19. This study mainly aimed to (1) investigate behavioral intentions of COVID-19 vaccination under various specific scenarios, and (2) associated factors of the afore-mentioned vaccination intentions.
A random anonymous telephone survey interviewed 450 Chinese adults from September 16-30, 2020 in Hong Kong, China. Nine scenarios of behavioral intentions of COVID-19 vaccinations were measured combining effectiveness (80% versus 50%), safety (rare versus common mild side effect), and cost (free versus HK$ 500).
The prevalence of behavioral intentions of COVID-19 vaccination under the 9 specific scenarios was very low and varied greatly (4.2% to 38.0%). The prospective countries of manufacture also influenced vaccination intention (eg, Japan: 55.8% vs China: 31.1%). Only 13.1% intended to take up COVID-19 vaccination at the soonest upon its availability. The attributes of effectiveness and side effect influenced vaccination intention most. Positively associated factors of behavioral intentions of COVID-19 vaccination included trust/satisfaction toward the government, exposure to positive social media information about COVID-19 vaccines, descriptive norms, perceived impact on the pandemic, perceived duration of protectiveness, and life satisfaction.
Intention of COVID-19 vaccination was low in the Hong Kong general population, especially among younger people, females, and single people. Health promotion is warranted to enhance the intention. The significant factors identified in this study may be considered when designing such health promotion. Future research is required to confirm the findings in other countries. Such studies should pay attention to the specific context of cost, safety, and effectiveness, which would lead to different responses in the level of behavioral intention of COVID-19 vaccination (BICV).
新冠肺炎(COVID-19)疫苗的接种率对于控制 COVID-19 至关重要。本研究主要目的在于:(1)在不同具体场景下,调查 COVID-19 疫苗接种的行为意向;(2)探讨上述接种意向的相关因素。
2020 年 9 月 16 日至 30 日,在中国香港,通过随机匿名电话调查,对 450 名成年人进行了访谈。共测量了 9 种 COVID-19 疫苗接种行为意向场景,结合了有效性(80% 对 50%)、安全性(罕见对常见轻度副作用)和成本(免费对 500 港元)。
9 种特定场景下 COVID-19 疫苗接种行为意向的流行率非常低,差异很大(4.2%至 38.0%)。预期的疫苗生产国也影响了接种意向(例如,日本:55.8%对中国:31.1%)。仅有 13.1%的人打算在疫苗供应后尽快接种 COVID-19 疫苗。有效性和副作用的属性对疫苗接种意向影响最大。COVID-19 疫苗接种行为意向的正向关联因素包括对政府的信任/满意度、接触到有关 COVID-19 疫苗的积极社交媒体信息、描述性规范、对大流行的影响感知、保护效力持续时间和生活满意度。
在香港普通人群中,COVID-19 疫苗接种意向较低,尤其是在年轻人、女性和单身人群中。需要进行健康促进以增强接种意向。本研究确定的重要因素在设计此类健康促进时可加以考虑。需要进一步的研究来证实其他国家的发现。此类研究应注意成本、安全性和有效性的具体背景,这将导致 COVID-19 疫苗接种行为意向(BICV)水平的不同反应。